1. Home
  2. ATEC vs ABCL Comparison

ATEC vs ABCL Comparison

Compare ATEC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$8.24

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.18

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEC
ABCL
Founded
1990
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ATEC
ABCL
Price
$8.24
$5.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
5
Target Price
$22.00
$8.40
AVG Volume (30 Days)
4.6M
8.8M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
15.04
10.91
EPS
N/A
N/A
Revenue
$101,739,000.00
$75,128,000.00
Revenue This Year
$18.97
N/A
Revenue Next Year
$16.70
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$6.82
$1.97
52 Week High
$23.29
$6.52

Technical Indicators

Market Signals
Indicator
ATEC
ABCL
Relative Strength Index (RSI) 42.18 64.05
Support Level $6.82 $3.32
Resistance Level $16.58 $5.63
Average True Range (ATR) 0.52 0.45
MACD 0.13 0.00
Stochastic Oscillator 38.04 73.67

Price Performance

Historical Comparison
ATEC
ABCL

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: